1. Rohde, David, Brinks, Henriette, Ritterhoff, Julia, Ren, Shumei, Most, Patrick. 2010. S100A1 gene therapy for heart failure: a novel strategy on the verge of clinical trials. In Journal of molecular and cellular cardiology, 50, 777-84. doi:10.1016/j.yjmcc.2010.08.012. https://pubmed.ncbi.nlm.nih.gov/20732326/
2. Yu, Zhe, Zhang, Yan, Tang, Zhe, Wang, Tao, Liu, Jihong. 2019. Intracavernosal Adeno-Associated Virus-Mediated S100A1 Gene Transfer Enhances Erectile Function in Diabetic Rats by Promoting Cavernous Angiogenesis via VEGF-A/VEGFR2 Signaling. In The journal of sexual medicine, 16, 1344-1354. doi:10.1016/j.jsxm.2019.06.011. https://pubmed.ncbi.nlm.nih.gov/31378707/
3. Ritterhoff, J, Most, P. 2012. Targeting S100A1 in heart failure. In Gene therapy, 19, 613-21. doi:10.1038/gt.2012.8. https://pubmed.ncbi.nlm.nih.gov/22336719/
4. Most, Patrick, Pleger, Sven T, Völkers, Mirko, Remppis, Andrew, Koch, Walter J. . Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. In The Journal of clinical investigation, 114, 1550-63. doi:. https://pubmed.ncbi.nlm.nih.gov/15578088/
5. Pleger, Sven T, Remppis, Andrew, Heidt, Beatrix, Koch, Walter J, Most, Patrick. 2005. S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction. In Molecular therapy : the journal of the American Society of Gene Therapy, 12, 1120-9. doi:. https://pubmed.ncbi.nlm.nih.gov/16168714/
6. Most, Patrick, Raake, Philip, Weber, Christophe, Katus, Hugo A, Pleger, Sven T. . S100A1 gene therapy in small and large animals. In Methods in molecular biology (Clifton, N.J.), 963, 407-20. doi:10.1007/978-1-62703-230-8_25. https://pubmed.ncbi.nlm.nih.gov/23296625/
7. Duarte-Costa, S, Castro-Ferreira, R, Neves, J S, Leite-Moreira, A F. 2014. S100A1: a major player in cardiovascular performance. In Physiological research, 63, 669-81. doi:. https://pubmed.ncbi.nlm.nih.gov/25157660/